drugset / Trial / NCT00542035
A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
RandomizedParallel-groupTriple-blindSupportive care
Summary
This is a Phase 2 study designed to test the ability of investigational study drug ARRY-371797 to reduce pain either perioperatively or postoperatively in a third molar extraction pain model, and to further evaluate the drug's safety. Approximately 150 subjects from the US will be enrolled in this study.
Timeline
- Start
- 2007-11-11
- Primary completion
- 2008-02-11
- Completion
- 2008-02-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ARRY-371797 | Small molecule | — | Oral |
Indications
No indication recorded.